Showing 1,041 - 1,060 results of 2,268 for search '"Polycystic ovary syndrome"', query time: 0.13s Refine Results
  1. 1041

    Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia by Moushira Zaki, Walaa Basha, Hala T. El-Bassyouni, Safinaz El-Toukhy, Tamer Hussein

    Published 2018-12-01
    “…The aim of the present study is to investigate DNA damage profile in obese premenopausal women and its relation to the risk of MS, polycystic ovary syndrome (PCOS) and history of recurrent pre-eclampsia. …”
    Get full text
    Article
  2. 1042
  3. 1043

    Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome by Junyu Zhai, Shang Li, Min Hu, Fangfang Di, Jiansheng Liu, Yanzhi Du

    Published 2020-04-01
    “…Abstract Background The interface between environmental risk factors and genetic factors could contribute to the pathogenesis of hyperandrogenism and insulin resistance in polycystic ovary syndrome (PCOS); however, the underlying complex mechanism remains to be elucidated. …”
    Get full text
    Article
  4. 1044
  5. 1045

    Evaluation of Bodily Pain Associated with Polycystic Ovary Syndrome: A Review of Health-Related Quality of Life and Potential Risk Factors by Kuan-Ta Lu, Yu-Cheng Ho, Chen-Lin Chang, Kuo-Chung Lan, Cheng-Chun Wu, Yu-Ting Su

    Published 2022-12-01
    “…Polycystic ovary syndrome (PCOS) is the most common reproductive disease affecting the hormone and metabolic status of women. …”
    Get full text
    Article
  6. 1046
  7. 1047
  8. 1048

    Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports by Sills, E. Scott, Perloe, Mark, Tucker, Michael J., Kaplan, Carolyn R., Schattman, Glenn L., Genton, Marc G.

    Published 2010
    “…Background This investigation was undertaken to describe patient perception and awareness of the polycystic ovary syndrome (PCOS), the most common cause of anovulation/oligoovulation among women of reproductive age. …”
    Get full text
    Article
  9. 1049

    A systematic review and meta-analysis of polycystic ovary syndrome and mental health among black Asian minority ethnic populations by Delanerolle, G, Ayis, S, Barzilova, V, Phiri, P, Zeng, Y, Ranaweera, S, Shetty, A, Haque, N, Kar, D, Majumder, K, Rathod, S, Raymont, V, Shi, JQ, Hapangama, D

    Published 2022
    “…<p><strong>Background</strong> Polycystic Ovary Syndrome (PCOS) is a chronic and a common gynaecological condition impacting women of reproductive age. …”
    Internet publication
  10. 1050
  11. 1051

    BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study by Louwers, Y, Rayner, N, Herrera, B, Stolk, L, Groves, C, Barber, T, Uitterlinden, A, Franks, S, Laven, J, McCarthy, M

    Published 2014
    “…INTRODUCTION: Polycystic Ovary Syndrome (PCOS) has a strong genetic background and the majority of patients with PCOS have elevated BMI levels. …”
    Journal article
  12. 1052

    Kelulut honey improves folliculogenesis, steroidogenic, and aromatase enzyme profiles and ovarian histomorphology in letrozole-induced Polycystic Ovary Syndrome Rats by Mohd Kamal, Datu Agasi, Ibrahim, Siti Fatimah, Ugusman, Azizah, Mohamad Zaid, Siti Sarah, Mokhtar, Mohd Helmy

    Published 2022
    “…Polycystic ovary syndrome (PCOS) has been linked to aberrant folliculogenesis and abnormalities in the aromatase enzyme (Cyp19a1) and the steroidogenic enzyme, 17-alpha-hydroxylase (Cyp17a1) expression. …”
    Article
  13. 1053

    Correlation between Selected Clinical Symptoms and Severity of Aggression, Impulsiveness and Their Selected Behavioral Manifestations in Patients with Polycystic Ovary Syndrome Phenotype A by Aleksandra Barabasz-Gembczyk, Wojciech Mędrala, Patryk Rodek, Barbara Alli-Balogun, Jan Chrobak, Marlena Cwynar, Dominika Sikora, Mariusz Wójtowicz, Grzegorz Franik, Paweł Madej, Krzysztof Kucia

    Published 2023-05-01
    “…Previous studies on aggressiveness and impulsiveness in women with polycystic ovary syndrome (PCOS) are ambiguous. Furthermore, no biochemical or clinical factors related to these variables have been definitively confirmed. …”
    Get full text
    Article
  14. 1054

    Reducing the Risk of Pre-Eclampsia in Women with Polycystic Ovary Syndrome Using a Combination of Pregnancy Screening, Lifestyle, and Medical Management Strategies by Jim Parker, Claire O’Brien, Christabelle Yeoh, Felice L. Gersh, Shaun Brennecke

    Published 2024-03-01
    “…Polycystic ovary syndrome (PCOS) is a multisystem disorder that presents with a variety of phenotypes involving metabolic, endocrine, reproductive, and psychological symptoms and signs. …”
    Get full text
    Article
  15. 1055
  16. 1056

    Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials by Mohammed Altigani Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al-Rifai, Stephen L. Atkin, Thozhukat Sathyapalan

    Published 2022-10-01
    “…Context: Polycystic ovary syndrome (PCOS) is one of the commonest endocrine disorders affecting women of reproductive age, and metformin is a widely used medication in managing this condition. …”
    Get full text
    Article
  17. 1057
  18. 1058

    The Prevalence of Fallopian Tube Occlusion in Women with Polycystic Ovary Syndrome Seems Similar to Non-Subfertile Women: A Retrospective Cohort Study by Stefan Ghobrial, John Preston Parry, Iris Holzer, Judith Aschauer, Clara Selzer, Andreas Brezina, Samir Helmy-Bader, Johannes Ott

    Published 2022-09-01
    “…With hormonal shifts influencing tubal secretions, it has been argued that subfertile women with polycystic ovary syndrome (PCOS) have lower tubal patency. …”
    Get full text
    Article
  19. 1059

    Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment by Yali Liu, Jiaying Lin, Xi Shen, Qianqian Zhu, Yanping Kuang

    Published 2023-03-01
    “…BackgroundWomen who have polycystic ovary syndrome (PCOS) with high body mass index (BMI) typically have an attenuated ovarian response and decreased follicular size, which are linked to unfavourable clinical outcomes following in vitro fertilization (IVF) therapy. …”
    Get full text
    Article
  20. 1060

    Association of miRNA − 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome by Nearmeen M. Rashad, Marwa Abdel-Monem Ateya, Yasser S. Saraya, Walid Mohamed Elnagar, Khaled Fathy Helal, Mohamed El-Bakry Lashin, Amr Ahmed Abdelrhman, Ayman E. Alil, Mohammed S. Yousef

    Published 2019-05-01
    “…Abstract Background Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder characterized by obesity, hyperandrogenism, and insulin resistance (IR). …”
    Get full text
    Article